Keyword: generic drugs

Plant Construction & Process Technology

Chances and Hurdles for Biosimilars

07.10.2015 - With biosimilars the pharmaceutical industry and health-care business move into a relatively young discipline with high sales potential. The follow-up drugs of biopharmaceuticals...

News

Mylan Makes New Bid for Perrigo

10.09.2015 - Mylan has announced a fresh $27.14 billion offer for generic drug and ingredients maker Perrigo. The Ireland-based drugmaker previously rejected several offers from its Netherlands...

News

US Sandoz Arm Fights US Overpay Lawsuit

18.06.2015 - Sandoz, Inc., the US arm of Novartis’ generic drugs division, is asking the Supreme Court of the US state of Mississippi to reverse a county court’s $38.2 million judgment against...

News

Mallinckrodt Challenge Says FDA Overstepped Bounds

08.06.2015 - An unusual lawsuit claiming the Food and Drug Administration (FDA) overstepped its bounds by deciding that two generic drugs used to treat attention deficit hyperactivity disorder...

News

Dr Reddy’s Pleased With Fiscal 2015 Performance

15.05.2015 - India-based generics producer Dr Reddy's Laboratories is pleased with its performance in fiscal 2015 (March 31) achieved despite currency volatility in some emerging market...

Markets & Companies

Current and Future Trends for Pharmaceutical Logistics

06.05.2015 - A wind of change is in the air when it comes to logistics in the pharmaceutical industry. Although most companies are still quite optimistic with regard to the current business...

News

Mylan Sweetens its Bid for Perrigo

30.04.2015 - Still being pursued by Israeli generics giant Teva, Netherlands-based drugmaker Mylan has increased its offer to acquire the issued and to-be-issued shares of smaller generics...

News

Mylan Board Unanimously Rejects Teva’s Bid

28.04.2015 - In its first reaction to the hostile takeover bid by Israeli generics giant Teva, the board of Dutch-based drugmaker Mylan has unanimously rejected the more than $40 billion offer...